We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+4.75%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$58.3B
AUM Growth
-$2.64B
Cap. Flow
-$4.37B
Cap. Flow %
-7.48%
Top 10 Hldgs %
70.23%
Holding
105
New
4
Increased
22
Reduced
49
Closed
9

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$180M
2
DELL icon
Dell
DELL
+$81.4M
3
EXPE icon
Expedia Group
EXPE
+$66.1M
4
PWR icon
Quanta Services
PWR
+$66.1M
5
LRCX icon
Lam Research
LRCX
+$43.4M

Sector Composition

Rank Sector Weight
1 Technology 11.58%
2 Consumer Discretionary 5.68%
3 Communication Services 4.51%
4 Financials 2.69%
5 Healthcare 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
51
Amphenol
APH
$209B
$156M 0.27%
2,400,000
+320,000
+15% +$20.7M
TER icon
52
Teradyne
TER
$59.3B
$153M 0.26%
1,144,017
-997
-0.1% -$134K
AMZN icon
53
PUT
Amazon
AMZN
$2.96T
$140M 0.24%
750,000
META icon
54
PUT
Meta Platforms (Facebook)
META
$1.51T
$123M 0.21%
215,000
LOW icon
55
Lowe's Companies
LOW
$125B
$122M 0.21%
449,078
-423
-0.1% -$102K
EDU icon
56
New Oriental
EDU
$8.98B
$119M 0.2%
1,563,597
-1,344
-0.1% -$92.1K
SHW icon
57
Sherwin-Williams
SHW
$89.8B
$117M 0.2%
306,970
-282
-0.1% -$98.4K
KROS icon
58
Keros Therapeutics
KROS
$221M
$110M 0.19%
1,897,601
+298,694
+19% +$14.8M
XYZ
59
Block Inc
XYZ
$47.5B
$105M 0.18%
1,566,200
AMT icon
60
American Tower
AMT
$80.4B
$99.7M 0.17%
428,730
-395
-0.1% -$87.6K
AKRO
61
DELISTED
Akero Therapeutics
AKRO
$95.4M 0.16%
3,325,004
-2,216
-0.1% -$57.8K
SPGI icon
62
S&P Global
SPGI
$120B
$87.6M 0.15%
169,548
-152
-0.1% -$75.2K
NVDA icon
63
NVIDIA
NVDA
$5.42T
$82M 0.14%
674,953
-694,217
-51% -$82M
SRPT icon
64
Sarepta Therapeutics
SRPT
$1.77B
$79.2M 0.14%
633,845
+75,000
+13% +$10.4M
BPMC
65
DELISTED
Blueprint Medicines
BPMC
$66.5M 0.11%
718,928
-175,000
-20% -$17.4M
YUM icon
66
Yum! Brands
YUM
$41.1B
$65.1M 0.11%
465,951
-418
-0.1% -$55.6K
RYTM icon
67
Rhythm Pharmaceuticals
RYTM
$7.96B
$61.2M 0.1%
1,167,700
+167,700
+17% +$8.04M
TSM icon
68
PUT
TSMC
TSM
$2.18T
$60.8M 0.1%
350,000
GOOGL icon
69
PUT
Alphabet (Google) Class A
GOOGL
$4.33T
$58M 0.1%
350,000
CMG icon
70
Chipotle Mexican Grill
CMG
$41.5B
$57.7M 0.1%
1,001,250
-1,875,000
-65% -$104M
GE icon
71
GE Aerospace
GE
$384B
$56.6M 0.1%
300,000
NVDA icon
72
PUT
NVIDIA
NVDA
$5.42T
$55.9M 0.1%
460,000
-690,000
-60% -$81.5M
ESTC icon
73
Elastic
ESTC
$7.81B
$54M 0.09%
703,716
-744,904
-51% -$73.5M
BCRX icon
74
BioCryst Pharmaceuticals
BCRX
$2.4B
$53.9M 0.09%
7,093,822
-5,662
-0.1% -$43K
PATH icon
75
UiPath
PATH
$7.8B
$52M 0.09%
4,061,276

Similar funds

Alkeon Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Alkeon Capital Management held 105 positions worth $58.3B, down 4.3% from $61B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Alkeon Capital Management withdrew a net $4.37B in Q3 2024, closing 9 positions and reducing 49 holdings. Its most notable exit was Baidu, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Alkeon Capital Management opened a new position in HubSpot worth $15.9M.

  • Alkeon Capital Management's largest Q3 2024 buy was HubSpot: 30,000 shares worth $15.9M.
  • Alkeon Capital Management added most to Applied Materials in Q3 2024, an estimated $180M increase.
  • Alkeon Capital Management's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $462M.
  • Alkeon Capital Management fully exited Baidu in Q3 2024, selling an estimated $149M.
  • Alkeon Capital Management's ten largest holdings make up 70% of its $58.3B portfolio in Q3 2024.
  • Alkeon Capital Management opened 4 new positions and closed 9 in Q3 2024.
  • Alkeon Capital Management's portfolio value fell 4.3% quarter-over-quarter to $58.3B.

Based on Alkeon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.